Germline Brca1/2 Pathogenetic Variants (Gbrca1/2 Pv) Affect Outcome Of Hormone (Hr)-Positive Her2-Negative Metastatic Breast Cancer (Mbc) Patients (Pts) Treated With Cyclin-Dependent Kinase 4/6 Inhibitor (Cdk 4/6I) Plus Endocrine Therapy (Et): The Break Study
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Germline Brca1/2 Pathogenetic Variants (Gbrca1/2 Pv) Affect Outcome Of Hormone (Hr)-Positive Her2-Negative Metastatic Breast Cancer (Mbc) Patients (Pts) Treated With Cyclin-Dependent Kinase 4/6 Inhibitor (Cdk 4/6I) Plus Endocrine Therapy (Et): The Break Study ### Output: 